Running title: Keratinocyte growth factor increases thymic output Nonstandard abbreviations: RTE, recent thymic emigrants; TBI, total body irradiation; KGF, keratinocyte growth factor, PBPCT, peripheral blood progenitor cell transplantation. suggest increased thymic-dependent reconstitution in these animals. Of note, the humoral response to a T cell dependent neo-antigen was significantly higher in the KGF-treated animals compared to the control animals. Thus, our findings suggest that KGF may be a useful adjuvant therapy to augment T cell reconstitution after human PBPC transplantation.
Introduction
Opportunistic infections due to protracted immunodeficiency contribute to morbidity and mortality after peripheral blood progenitor cell (PBPC) transplantation. Thus, the recovery of the immune system after transplantation impacts significantly on the outcome of transplantation. To a great extent the integrity of a new immune system relies on the capacity of the thymus to generate naïve T cells; this is especially true for the CD4 + T cell compartment. [1] [2] [3] Only the naïve T cell pool has the broad repertoire of T cell receptor (TCR) specificities necessary to generate new immune responses. [4] [5] [6] In contrast to thymic repopulation, the normalization of T cell numbers by peripheral expansion of the pre-existing T cell pool results in a narrow TCR repertoire which may impair the ability to induce new immune responses. Injury to the thymic microenvironment is considered one of the major factors responsible for slow T cell immune reconstitution after transplantation and any interventions preserving thymic function could improve transplant outcomes. [4] [5] [6] [7] [8] Recombinant human keratinocyte growth factor (KGF; Palifermin, Kepivance™, Amgen USA) is currently licensed for the reduction of the incidence and duration of oral mucositis following transplantation for hematologic malignancies. 9 Exogenous KGF administration has also been shown to protect thymic epithelial cells (TECs) from injury induced by chemotherapy, radiation or oxidative stress in murine models. [10] [11] [12] [13] Prevention of thymic injury leads to improved thymopoiesis, as TECs nurture hematopoietic precursors and thereby ensure thymocyte development and maturation of newly generated T cells. 11, [13] [14] [15] KGF is a known stimulator of epithelial cell growth. 16, 17 The KGF receptor is expressed on TECs which produce interleukin-7
(IL-7) and as KGF increases IL-7 transcripts in the thymus, induction of IL-7 production is a possible effector mechanism. 13 Another might be increased resistance against apoptosis or enhancement of epithelial cell recovery as observed in other epithelial tissues following KGF treatment. [18] [19] [20] [21] KGF's effect as a protective and trophic factor for TECs supports the rationale for its ability to ensure thymocyte proliferation and maturation. A greater mass of true epithelial space should translate into greater de novo production of naïve T cells in the time period early after For personal use only. on November 12, 2017. by guest www.bloodjournal.org From transplantation as the TEC-thymocyte interaction is essential for T cell development. This hypothesis is supported by the observation that effective development of T cells needs seeding of precursor cells to a regularly structured thymic microenvironment 14 and the finding that exogenous KGF given to lethally irradiated, bone marrow (BM) reconstituted recipients resulted in supranormal thymocyte numbers. 13 However, the effects of KGF in rodents may be different compared to humans and thus careful evaluation of this agent in a non-human primate model of immune reconstitution after PBPC transplantation is critical for preclinical development. In addition, the use of non-human primates allows serial sampling of blood and lymph nodes (LNs)
as well as post-mortem analysis of the thymus, which is impossible in clinical trials. Furthermore, these autologous primate studies can differentiate the effects of KGF on immune function from factors complicating analysis in clinical trials, including the impact of the underlying disease necessitating transplantation, prior therapies, and alloreactivity.
Thus, in this study we evaluated the effect of KGF treatment on thymic architecture and T cell immune reconstitution after myeloablative total body irradiation (TBI) and autologous PBPC transplantation in healthy rhesus macaques. Our findings suggest that KGF protects thymic architecture and thus improves de novo T cell immune reconstitution even leading to an improved humoral response to a T cell dependent neo-antigen. Therefore, KGF may be a useful adjuvant therapy to reduce morbidity and mortality after PBPC transplantation via effects on the thymus and enhanced immune reconstitution.
Materials and Methods

Animals.
All animals were colony-bred rhesus macaques (Macaca mulatta) of Indian origin, maintained and used in accordance with the guidelines of the National Institutes of Health Guide for the Care and Table 1 ). These animals were free of known infectious or immunologic diseases.
Study Design.
One group of animals (n=4) received 250µg/kg body weight keratinocyte growth factor (KGF, palifermin, Kepivance®, Amgen, Thousand Oaks, CA) by intravenous bolus on day -5 (day 0=day of transplantation), a second group of animals (n=2) received KGF day -5, -4 and -3 before TBI as well as on day 0, +1 and +2 based on the dosage scheme in murine studies and clinical trials. 9, 11 Besides mild erythema of the palms after KGF treatment no side effects were observed.
In addition, at 12 months after treatment no epithelial tumor development in any of the animals was observed. These animals were compared to an age matched control group that was transplanted but not treated with KGF (n=5) ( Figure 1 ). All animals were vaccinated 3.5 months after transplantation with 10 12 particles of a replication-incompetent Adenovirus serotype 5 vector encoding for HIV-1 envelope protein gp140 formulated in sterile saline and delivered into the quadriceps muscle by use of a needle and syringe.
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Mobilization and collection of CD34 + hematopoietic progenitor cells.
PBPCs were mobilized with recombinant human G-CSF (10 µg/kg; Amgen, Thousand Oaks, CA) in combination with SCF (200 µg/kg; Amgen, Thousand Oaks, CA) administered by subcutaneous injection daily for four days. Mobilized PBPCs were collected by leukapheresis as described 23 and isolated using density gradient centrifugation. CD34 + cell enrichment was performed using the 12.8 Immunoglobulin-M (IgM) anti-CD34 biotinylated antibody and MACS streptavidin microbeads (Miltenyi Biotec, Auburn, CA). The CD34 + cell concentration in peripheral blood and the purity of the MACS-sorted CD34 + cells were analyzed by flow cytometry. The cells were frozen in 90%
fetal bovine serum mixed with 10% dimethyl sulfoxide. The viability of the cells after thawing was >95% in all animals measured by trypan blue staining (Supplemental Table 1 + selected PBPCs (purity 85-96%) were re-infused. The CD34 + cell numbers infused into each animal were matched between the three groups (Supplemental Table 1 ). The graft was thawed and reinfused via a central venous catheter. A day later, the animals were started on G-CSF 5µg/kg/day intravenously until the total white blood cell count reached 6000/µL.
Collection of peripheral blood and lymph node samples.
Blood was drawn and a lymph node was removed for baseline analysis prior to mobilization and transplantation. All animals were followed for one year after transplantation ( Figure 1 ). Blood was drawn every month up to nine months and thereafter at twelve months post transplantation.
Inguinal or axillary LNs were removed at one, three, six and twelve months post transplantation.
Twelve to fourteen months after transplantation the animals were euthanized and all lymphoid tissue was collected.
Cell preparation.
PBMCs were isolated from citrated venous blood by density gradient sedimentation using FicollHypaque (Pharmacia, Uppsala, Sweden). Mononuclear cells were isolated from lymph node samples by gentle mechanical disruption of tissues in RPMI (HyClone Laboratories, Logan, UT)
supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, penicillin, and streptomycin.
The cells were passed through a 100-µm mesh filter to remove any remaining tissue fragments.
Phenotyping of cells by immunofluorescent staining and flow cytometric analysis.
0.25-1.0 x 10 6 cells from PBMC and lymph node samples were resuspended in wash buffer (PBS/0.5% BSA) and incubated with directly-conjugated mAbs (Supplemental Table 2 ) as described. 24 For intracellular analysis of Ki67 expression, cells were first stained for the cell surface markers CD4, CD8β, and CD95, before incubation in 2x fixation/permeabilization solution This resulted in >98% pure populations of T cell subsets. Cell pellets were frozen and TREC levels were measured by qPCR directly on cell lysates as previously described. 5 PCR was performed on ABI Prism 7700 sequence detector (Applied Biosystems).
Histology and immunohistochemistry.
At necropsy, tissues from the following sites were harvested: tonsils, thymus, lymph nodes, spleen, Peyer's patches and BM. A portion of each tissue was snapfrozen in OCT and kept at -80 0 C, the remaining tissue was fixed in 10% formalin and paraffin-embedded.
Immunohistochemical staining with anti-CD3 (LabVision), anti-CD20, anti-high molecular weight keratin, anti-Ki67 (all from DakoCytomation) were performed using Envision Plus detection system (DakoCytomation) with DAB as chromogen on a DakoAutomated immunostainer.
CDR3 spectratyping.
CDR3 spectratyping was performed on PBMCs as previously described with modifications. 26 cDNA was amplified with Vbeta-specific-5' and FAM-labeled C-3' primers previously described 27 and analyzed on a 3100 Genetic Analyzer using capillary electrophoresis in the presence of For personal use only. on November 12, 2017. by guest www.bloodjournal.org From standards labeled with ROX dye. Acquired data were analyzed using Genescan and Genotyper software.
Quantification of spectratyping results.
In order to quantify the deviation of the peak spectrum of a given Vβ from a Gaussian distribution and not simply rely on qualitatively visual judgement we developed a new method to calculate Skewness and Kurtosis of the Vβ's distribution of the peak areas. We subtracted the Kurtosis of a Gaussian distribution (which is 3) from the Kurtosis calculated for the Vβ peak area distributions to compare them to Gaussians.
Skewness is defined as µ3/σ 3 where µ3 is the third moment about the sample mean and σ is the standard deviation. For a sample size of n the skewness would be Kurtosis is defined as µ4/σ 4 where µ4 is the fourth moment about the sample mean and σ is the standard deviation. For a sample size of n the kurtosis would be
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From Kurtosis measures whether a distribution is flat or has isolated peaks. Data sets with a distinct peak near the mean and heavy tails will have a high kurtosis. Flat data sets will have a low kurtosis.
To obtain a kurtosis score for a given monkey we averaged over the absolute values of the (kurtosis-3) of all of its Vβ samples. A large kurtosis score thus indicates that the Vβ spectra of the monkey had an overall strong deviation from Gaussian distributions ( Table 1) .
Analysis of humoral responses against HIV-1 envelope.
HIV envelope protein supernatant was coated overnight on Immunol-2 HB microtiter plates 
Statistical analysis.
Statistical analysis was conducted with the program S-plus (StatSci Division, MathSoft Inc.).
Unless otherwise specified, simple 2 group comparisons were conducted using rank-based nonparametric tests, such as the Wilcoxon test. To examine differences in responses of interest over time, separate linear models were fit to each animal using all measurements between 30 and 180 days after the procedure and the slopes of these models were compared between groups. These models were used to test for group differences in T cell populations, and the percentage of T cells that were Ki67 + .
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Results
Transplantation and Engraftment
Healthy adolescent rhesus macaques underwent mobilization of PBPC with G-CSF and SCF ( Figure 1 ) and PBMCs were collected by leukapheresis. The animals were thereafter conditioned with myeloablative TBI and transplanted with purified autologous CD34 + PBPC (Figure 1 and Supplemental Table 1 ). Four animals received KGF at a single dose of 250 µg/kg body weight before transplantation and two animals received repetitive treatment of KGF three times before and three times after conditioning, simulating the regimen used for autologous PBPC transplants in humans. 9, 21 The KGF-treated animals were compared to an age and CD34 + cell dose-matched control group of five monkeys concurrently transplanted without KGF treatment. All animals engrafted (leucocytes >1000/µl, neutrophils >500/µl) 8 to 13 days after transplantation.
KGF treatment increases naïve T cell reconstitution.
One month after undergoing TBI and PBPC transplantation, all animals experienced a dramatic depletion of peripheral blood (PB) and LN T cells (Supplemental Figure 1A and Figure 2A , respectively). In all animals there was a rapid recovery of CD8 + T cells, whereas the recovery of CD4 + T cells showed slower kinetics. This led to an inversion of the CD4/CD8 ratio during the first three months after transplantation (data not shown), as previously reported in humans 28, 29 and in rhesus macaques. 24 There was no difference between treatment groups in reconstitution of total T cell numbers in peripheral blood; therefore, the phenotype and frequency of defined T cell subsets was analyzed in further detail. 24, 25 As all animals studied were adolescents at time of study entry, naïve T cells were the most prevalent T cell phenotype both in the CD4 + and CD8 + T cell populations prior to transplantation ( Figures 2B and C Figure 1) .
KGF increases TREC levels and decreases peripheral T cell proliferation.
To estimate thymic output we measured TREC within sorted CD4 + and CD8 + T cells from PB obtained prior to and post transplantation. In all animals one month after transplantation TREC levels were very low compared to pre-transplant levels ( Figure 3A-B 
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+ T cells (p=0.05). The differences were most notable and significant at the first month post transplantation (p=0.004 for CD4 + T cells, p=0.004 for CD8 + T cells). Taken together these data suggest that the KGF-treated animals had higher thymic output of de novo generated T cells than control animals and thus experienced less peripheral T cell expansion to achieve the same degree of reconstitution of absolute T cell numbers.
Broader T cell receptor repertoire diversity with KGF treatment.
To further determine the source and quality of phenotypically naïve CD4 + and CD8 + T cells post transplantation, we evaluated the diversity of TCRs at one year after transplantation using TCRB CDR3 spectratyping. 31 A limited TCR repertoire suggests that most T cells have expanded from a limited pool of parent T cells whereas a broader repertoire suggests a greater contribution from de novo generated naïve T cells. The breadth of the TCR repertoire was derived from the spectratyping data by ranking the animals according to the product of the skewness and kurtosis of their repertoires -two measures of diversity -as described in the Methods. The majority of KGF-treated animals showed a broader TCR repertoire compared to the untreated animals;
indeed, the top four ranked repertoires were all from KGF-treated animals (Table 1) . However, the difference in TCR repertoire between KGF-treated and control animals did not reach statistical significance. One KGF-treated animal (RQ3602) had a highly skewed repertoire, even with well-preserved thymic architecture, and this precluded deriving any statistically significant correlation between KGF treatment and TCR diversity from this small sample size.
T and B cell immune responses after neo-antigen challenge.
We challenged the animals with a T cell dependent neo-antigen at 3. For personal use only. on November 12, 2017. by guest www.bloodjournal.org From neutralizing antibodies elicited against HIV-1 envelope. In most animals peak levels of antibodies were observed at six weeks after immunization. 32 Five out of the six KGF-treated and three of five control animals had detectable levels of antibodies against HIV-1 envelope (Figure 4) . Notably, the KGF-treated animals had significantly higher median antibody titers than the control animals (p=0.04 by a one-sided Mann-Whitney test) suggesting that they were capable of mounting a superior humoral response to a T cell-dependent neo-antigen.
Preserved thymic architecture with a greater frequency of double positive thymocytes in KGFtreated animals.
As KGF primarily enhances epithelial cell growth and thereby may protect TECs, we performed histologic and phenotypic analysis of the thymus 12-14 months post-transplantation to determine whether preserved thymic architecture might underlie the beneficial reconstitutive effects of KGF treatment described above. Slides were analyzed while blinded to the treatment groups and thymic architecture was scored according to three grades ( Figure 5 and Supplemental Figure 2 ).
Grade 1 thymuses had completely intact architecture with preserved lobular structures and welldefined cortical and medullary areas with high cellularity. Six animals were scored thus; one animal (RQ4715) had received multiple doses of KGF and the others (RQ3602, RQ2932, CJ2T, RQ2614) had received a single dose. In addition, one control animal (RQ3576) showed thymic structure of this grade. Grade 2 thymuses had areas of well-preserved architecture and high cellularity but with some degree of thymic atrophy in other areas. One animal that received multiple doses of KGF (RQ4831) and one untreated animal (CJ5D) exhibited thymuses of this type. Grade 3 thymuses showed severe thymic atrophy, defined by fat replacement, decreased cortical thickness, cystic changes of the epithelium and low cellularity. All three remaining control animals belonged to this group. In summary, all six KGF-treated animals had no or little thymic atrophy while three out of five control animals had severe thymic atrophy. The weight of the thymuses at autopsy did not correlate with the quality of the thymic architecture ( In addition, when the animals were ranked according to their thymic histology those with preserved thymic structure (grades 1 and 2) showed significantly better reconstitution of absolute counts of peripheral blood naïve CD4 + T cells at months three (p=.017), four (p=0.017), six (p=0.017), and eight (p=0.033), as well as the mean over 6-12 months (p=0.009) than the animals with poor thymic architecture (grade 3) (Supplemental figure 3A) . The recovery of naïve CD8 + T cells also tended to be greater in the animals with preserved thymic architecture and was significantly so at six months (p=0.033) (Supplemental figure 3B) . Furthermore, poor thymic architecture, as determined histologically, was also associated with a poor ranking in terms of TCR repertoire diversity (Supplemental Figure 4) . While these observations do not bear upon our conclusions regarding the effect of KGF, they serve to confirm the known association between thymic function and histology, naïve T cell numbers and repertoire diversity.
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From Finally, there were no histologically discernible differences in the architecture or cellularity of LNs, tonsils, spleen, BM or Peyer's patches between the KGF-treated and control animals. LNs showed follicular and paracortical hyperplasia in all animals, and the white pulp of the spleen was hyperplastic with prominent follicles in all animals besides two control animals (RQ3564, RC810) which showed regressive changes in the white pulp such as small germinal centers with hyaline changes (unpublished data).
Discussion
Patients after PBPC transplantation experience a prolonged period with increased risk of infections. Poor host immunity and presence of resistant organisms compromise the treatment of infections leading to increased morbidity and mortality after transplantation. The slow recovery of newly developed, naïve T cells is currently considered to be one of the most important determinants of immune competence after PBPC transplantation. 34 Thus, approaches to improve T cell immune reconstitution, particularly at the earliest time points after transplantation, are A depleted T cell compartment may be reconstituted through either a thymic-dependent or independent pathway. 35, 36 The thymic-dependent pathway results in de novo generation of naïve T cells with a more diverse TCR repertoire, while the thymic independent pathway relies on peripheral expansion of mature T cells with a consequently more limited TCR repertoire. 37 The latter tends to dominate the early time period after transplantation but is self-limiting as these T cells undergo apoptosis. 38, 39 Our data support the hypothesis that KGF promotes the thymic- For personal use only. on November 12, 2017. by guest www.bloodjournal.org From Clearly, the aim of augmenting early thymic output to reconstitute the naïve T cell pool is to reduce morbidity and mortality from infections and post-transplantation tumor relapse. The response to a T cell-dependent neo-antigen is a useful surrogate marker for the improvement of de novo immune reconstitution. The current recommendation for vaccination in the clinical setting is to wait 6-12 months after transplantation to increase the probability of an immune response. 42 Thus, it is promising that the KGF-treated animals in our study had significantly increased humoral responses to neo-antigen presented early after transplantation compared to the control group; this improved immunity might also apply to endogenous pathogens such as herpesviruses. 43 This finding, together with the observations discussed above, are particularly encouraging when taking into account that even in this large animal model with small groups, the majority of parameters of immune reconstitution measured were significant and suggested a clearly beneficial effect of KGF. That some measures of immune reconstitution were improved at later time points may be due to KGF having a primarily qualitative effect, rather than simply speeding up the reconstitution process as such. Importantly, short course KGF treatment was well-tolerated, free of side effects and effective. Other available approaches, including IL-7, may require prolonged administration, would not be expected to stimulate TECs directly and may have side-effects. 18, 19, 44 Whether KGF would have the same beneficial effects in the allogeneic transplantation setting needs to be confirmed either in large animal models or in clinical trials. In mice, KGF has been shown to improve T cell immune reconstitution, and decrease incidence and severity of graft versus host disease in allogeneic transplantation 11, 45 even in older subjects.
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Taken together, our data are in line with findings in mouse models and suggest that preservation of thymic architecture is a major determinant of naïve T cell reconstitution after PBPC transplantation and that treatment with KGF enhances this. Of note is the preservation of thymic architecture a year after transplantation even after a single dose of KGF. Older individuals with a natural involution of the thymus 5,30 undergoing a transplantation as well as patients undergoing haploidentical transplantation have a high risk for graft versus host disease and prolonged immune deficiency. 46 Thus, it is especially in these settings that KGF would be relevant not only Study design. Animals were mobilized with G-CSF/SCF for 4 days and PBMCs collected by leukapheresis, followed by CD34 + selection. They were transplanted after TBI. We compared three groups: one group received KGF once before, the second 3 times before and 3 times after conditioning. These animals were compared to a control group transplanted without KGF treatment. All were vaccinated with an HIV env vaccine 3.5 months after transplantation, and followed for 12 months after transplantation. They were euthanized and underwent necropsy to collect all lymphoid tissue at end of study. double negative (CD4 -CD8 -). The thymus of animals CJ5D and RQ3564 were not available for this analysis.
